Saturday, October 31, 2026

Infrastructure Investment

4 articles

Nevada Data Centers on Track to Consume 35% of State Power by 2030, Reshaping Energy Investment

Nevada Data Centers on Track to Consume 35% of State Power by 2030, Reshaping Energy Investment

A 2026 study projects Nevada data centers will account for 35% of the state's electricity consumption by 2030, signaling that AI infrastructure power demand has crossed into a systemic grid-level constraint. The shift is accelerating capital flows into utilities, power generation, and energy infrastructure M&A. Investors are repositioning toward AI-adjacent REITs and natural gas and nuclear assets as hyperscalers face rising electricity costs.

LM Salvado•
Nigeria's NSIA Deploys Sovereign Capital Into AI Infrastructure as Kasi LOS1 Goes Live

Nigeria's NSIA Deploys Sovereign Capital Into AI Infrastructure as Kasi LOS1 Goes Live

Nigeria's sovereign wealth fund, NSIA, has committed capital to AI infrastructure in a funding event timed with the commissioning of the Kasi LOS1 facility. Policy, regulation, subsea connectivity, and state capital are converging simultaneously. The move positions West Africa for a wave of local AI compute access within 6 to 18 months.

LM Salvado•
Network Automation Platform Netris Posts 622% Growth as AI Infrastructure Deployment Reaches 20+ Cloud Centers

Network Automation Platform Netris Posts 622% Growth as AI Infrastructure Deployment Reaches 20+ Cloud Centers

Netris captured 622% year-over-year revenue growth deploying network automation across 20+ AI cloud facilities, solving manual configuration error rates that reach 20%. The platform's expansion coincides with VCI Global operationalizing Southeast Asia's first NVIDIA-powered GPU computing center in Singapore, targeting Asia-Pacific's accelerating AI infrastructure market. Industry analysts project trillions in required AI infrastructure investment, with only hundreds of billions deployed to date.

ViaNews Editorial Team (Finance)•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com